Barclays Starts Blueprint Medicines (BPMC) at Equalweight

May 4, 2020 5:31 PM

Barclays analyst Peter Lawson initiates coverage on Blueprint Medicines (NASDAQ: BPMC) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found